Synthetic Optimization and MAPK Pathway Activation Anticancer Mechanism of Polyisoprenylated Cysteinyl Amide Inhibitors is a research paper published in Cancers (2021). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: SC1CA190505
National Institutes of Health
Grant: U54 MD007582
National Institutes of Health
Grant: 5U54MD007582-37
FAMU Center for Health Disparities Research
National Institutes of Health
Grant: 5SC1CA190505-04
Disrupting Polyisoprenylated Protein Function for Lung Cancer Therapy
FWCI
0.30
Citation Percentile
0.5%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals